Publications

Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models

Tang WW, Grewal R, Shresta S

Innate antiviral immunity against dengue virus

Makhluf H, Shresta S

Different STAT transcription complexes drive early and delayed responses to type I IFNs

Abdul-Sater AA, Majoros A, Plumlee CR, Perry S, Gu AD, Lee C, Shresta S, Decker T, Schindler C

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy

Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB

CD8+ T cells can mediate short-term protection against heterotypic dengue reinfection in mice

Zellweger RM, Tang WW, Eddy WE, King K, Sanchez MC, Shresta S

A novel iminosugar UV-12 with activity against the diverse viruses influenza and dengue (novel iminosugar antiviral for influenza and dengue)

Warfield KL, Plummer E, Alonzi DS, Wolfe GW, Sampath A, Nguyen T, Butters TD, Enterlein SG, Stavale EJ, Shresta S, Ramstedt U

CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice

Zelleweger RM, Eddy WE, Tang WW, Miller R, Shresta S

Mouse models for dengue vaccines and antivirals

Plummer EM, Shresta S

Mouse models to study dengue virus immunology and pathogenesis

Zellweger RM, Shresta S

Animal models in dengue

Plummer E, Shresta S